A Multicenter Phase 2 Study of the Glutaminase Inhibitor CB-839 in Combination with Paclitaxel in Patients with Advanced Triple Negative Breast Cancer (TNBC) Including Patients of African Ancestry and Non-African Ancestry May 10, 2018 Type of Cancer Breast Oncology Sponsor cALITHERA Protocol Number cx-839-007 To Learn More Call (201)-510-0950
